EyePoint Pharmaceuticals: Funding, Investors & Team (Oct 2026)
EyePoint Pharmaceuticals develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. The company have developed three approved products in either the U.S. or the EU for sustained release delivery of drug utilizing multiple generations of our Durasert technology system.
EyePoint Pharmaceuticals has raised $45.0M across 1 funding round on record, the most recent a Post-IPO Debt of $45.0M announced in Mar 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
EyePoint Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Mar 2022.
EyePoint Pharmaceuticals Funding Rounds
EyePoint Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
EyePoint Pharmaceuticals Funding Compared to Other Biotechnology Startups
EyePoint Pharmaceuticals' latest round of $45.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like EyePoint Pharmaceuticals in Biotechnology and Watertown
Companies Similar to EyePoint Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
EyePoint Pharmaceuticals Funding FAQs
What does EyePoint Pharmaceuticals do?
EyePoint Pharmaceuticals develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. The company have developed three approved products in either the U.S. or the EU for sustained release delivery of drug utilizing multiple generations of our Durasert technology system.
How much funding has EyePoint Pharmaceuticals raised?
EyePoint Pharmaceuticals has raised $45.0M across 1 round on record. The most recent is a Post-IPO Debt of $45.0M announced in Mar 2022.
When did EyePoint Pharmaceuticals last raise funding?
EyePoint Pharmaceuticals' most recent funding round on record is a Post-IPO Debt of $45.0M, announced in Mar 2022.
Who is the CEO of EyePoint Pharmaceuticals?
Paul Ashton is listed as CEO at EyePoint Pharmaceuticals.
Where is EyePoint Pharmaceuticals headquartered?
EyePoint Pharmaceuticals is based in Watertown, Massachusetts, United States.
How many employees does EyePoint Pharmaceuticals have?
EyePoint Pharmaceuticals is in the 101-250 employee band.
How does EyePoint Pharmaceuticals' funding compare to other Biotechnology startups?
EyePoint Pharmaceuticals' latest round of $45.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's EyePoint Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for EyePoint Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.